Cutera, Inc. (NASDAQ:CUTR)

tommyboy1969 (< 20) Submitted: 4/30/2011 11:05:44 AM : Start Price: $8.79 CUTR Score: -13.04

undervalued......

chakkar1 (< 20) Submitted: 8/5/2008 3:40:21 PM : Start Price: $11.75 CUTR Score: -44.54

$7+ in cash after earnings announced on 05-Aug-2008. Restructuring seems to be yielding results and $8-bottom may have set in after these results. Strong volume (3x average) on the upside. Looking for analysts to raise estimates.

ilyaz1 (70.86) Submitted: 5/12/2008 2:51:22 PM : Start Price: $11.38 CUTR Score: -33.64

A bit of a speculitive play. Great products, 52 week low, looking for a rebound. I belive the downside on this stock is limited.

kogenSF (34.20) Submitted: 4/7/2008 3:22:25 PM : Start Price: $13.42 CUTR Score: -45.88

This one is a bit of a risk. With the junk fax lawsuit hanging over them (what kind of company markets by junk fax anyway?) the stock may languish for a bit longer, but the product line is great. They just need to hire a new VP of sales and profesionalize that staff with some superstars. But I'm still going to recommend it as a buy.

shoshin3 (37.45) Submitted: 4/3/2008 12:57:58 PM : Start Price: $13.79 CUTR Score: -47.50

My best friend - a doctor in a small town is buying one of there machines. He looked at all the machines out there and said their product was by far the best. He said the sales people understood the science behind their product. He said the potential for use in dermatology is huge.

riizzoepq (20.59) Submitted: 12/4/2007 11:51:56 PM : Start Price: $15.77 CUTR Score: -47.79

Everyone needs to look younger and this group can do it. I think their equipments older, but maybe selling the same treatment on a discount will revive the earnings.

IamStillLearning (87.61) Submitted: 9/20/2007 8:38:15 PM : Start Price: $26.32 CUTR Score: -63.80

medical equip.
expect Q3 earing up. strong money flow in.
off long basing, break resistance at 25.55, should be ok at 26.66. expect at 30.

donflamenco (27.18) Submitted: 8/11/2007 2:12:22 PM : Start Price: $22.11 CUTR Score: -62.76

Solid company. Pearl product line looks to be successful; great Q2 '07 and stock is at 52-wk low. Fair valuation is $32.

KansasGold (89.12) Submitted: 5/30/2007 10:57:52 AM : Start Price: $25.97 CUTR Score: -64.77

another one of my beaten down stocks. earnings fit my M.O. have beat earnings consistly over the past year, and just had a bad quarter, a little bit of a legal scare and they lowered their 2007 estimates.

This doesn't bother me too much. The LED Cosmetic light treatments are fairly new, and expensive, but hitting the mainstream. I think this is gonna be the new trend in cosmetic treatments.

So to me, the stock is oversold, this is a growth industry and plus the company is doing a $25 million stock buyback.

There may be a bit more of a downside, but the upside significantly outweighs it.

1Ganador (28.59) Submitted: 4/7/2007 12:39:58 PM : Start Price: $28.99 CUTR Score: -77.73

Cutera has been on my stock list for a long-time. I own the stock in my real port and I believe it will do very well despite it's recent 30%+ correction due to pre-announced earnings miss. Management is straight forward and is bottom line oriented.

The company will rectify the sales numbers in the subsequent quarters and will continue with its expansion. It's going to take a while before the stock is back to it's recent highs, but it'll happen in the next 12-18 months. In the next 5 years, the stock will outperform all the indexes.

In my opinion, the only major risk to the story is aggressive pricing from competitors and patent litigation results that are negative to CUTR (If Palomar loses the current litigation with Candela, Cutera is still obligated to pay royalties).

interactdv (31.25) Submitted: 4/6/2007 8:59:20 AM : Start Price: $26.32 CUTR Score: -69.82

Overpriced at this time. Cutera has a wide selection of versatile, high quality lasers but the market is close to saturated. Projections of increased consumer expenditures in the cosmetics field are still heavily weighted towards procedures other than laser. New fraxel technology will increase revenues but Cutera only provides the equipment so will not be the most direct beneficiary. The fraxel technology patents are not held by Cutera. In the short term the stock is overpriced but with an improving cash flow they should be able to outperform the 500 for the long-term. Expect a short term correction as the price comes into line with their sales.

Bogeasy (70.92) Submitted: 4/5/2007 11:02:20 AM : Start Price: $26.61 CUTR Score: -70.66

Cosmetic Surgery growth model.

Uresh (94.65) Submitted: 2/1/2007 1:47:44 PM : Start Price: $31.99 CUTR Score: -75.45

Laser treatment for aging baby boomers. And there are a lot of them!